- Report
- November 2021
- 527 Pages
Global
From €3528EUR$4,000USD£3,100GBP
- Report
- November 2021
- 802 Pages
Global
From €4410EUR$5,000USD£3,875GBP
- Report
- November 2021
- 1184 Pages
Global
From €5292EUR$6,000USD£4,649GBP
- Report
- November 2021
- 1165 Pages
Global
From €5292EUR$6,000USD£4,649GBP
The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more